Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Depression - Major Depressive Disorder
Interventions
DRUG

desvenlafaxine succinate sustained release

Two tablets of 25 mg, single administration, under fed condition

DRUG

desvenlafaxine succinate sustained release

One tablet of 50 mg, single administration, under fed condition

DRUG

desvenlafaxine succinate sustained release

Two tablets of 25 mg, single administration, under fast condition

DRUG

desvenlafaxine succinate sustained release

One tablet of 50 mg, single administration, under fast condition

Trial Locations (1)

B-1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY